Envista Holdings (NVST)

Envista reports through two main business segments. Specialty Products & Technologies is its key revenue contributor and includes implant systems, regenerative solutions, prosthetics, orthodontic brackets, clear aligner-related offerings, lab products and associated digital treatment tools. Brands associated with this area include Nobel Biocare and Ormco, which are widely recognized in implant dentistry and orthodontics. The segment targets higher-value procedures where clinical outcomes, workflow integration and practitioner training are important.

The Equipment & Consumables segment supplies products such as dental imaging systems, instruments, restorative materials and other items used across dental offices and labs. These offerings support both routine care and more advanced procedures, giving Envista exposure to recurring demand as well as equipment replacement cycles. The company sells mainly through dental distributors and direct commercial channels, with North America its largest region, followed by Western Europe and other developed and emerging markets.

Envista became an independent public company after its separation from Danaher. Its strategy centers on building a focused dental platform with recognizable brands, broad clinical reach and products that connect traditional dental workflows with digital planning, imaging and treatment.